Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000083935 | SCV002181907 | uncertain significance | TNF receptor-associated periodic fever syndrome (TRAPS) | 2022-09-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The tyrosine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 97682). This variant has not been reported in the literature in individuals affected with TNFRSF1A-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 95 of the TNFRSF1A protein (p.His95Tyr). |
Mayo Clinic Laboratories, |
RCV003480056 | SCV004226300 | uncertain significance | not provided | 2022-06-08 | criteria provided, single submitter | clinical testing | PM2_supporting, PS4_supporting |
Unité médicale des maladies autoinflammatoires, |
RCV000083935 | SCV000116047 | not provided | TNF receptor-associated periodic fever syndrome (TRAPS) | no assertion provided | not provided |